Flavonoid-based composition for pharmaceutical, nutritional or cosmetic use having potentiated antioxidant action
Granted 7 Nov 2017 · 3 office actions
Assignee: GIULIANI S.P.A.
Law firm: Law firm · Log in to unlock
Attorney: Attorney · Log in to unlock
Inventors: Antonio Limitone, Giammaria Giuliani, Antonio Mascolo, Sergio Baroni +2 · Examiner: Sean Basquill · AU 1613 · TC 1600
Life of the application
13 dated eventsAbstract
The invention relates to a composition for pharmaceutical or nutritional or cosmetic use, formulated for oral or topical use and possessing antioxidant activity against free radicals, comprising: a) a Vitis vinifera seed, or seed and leaf, extract containing a combination of the flavonoids catechin and quercetin in a molar ratio in a range from 6:1 to 3:1, respectively, or a′) a Vitis vinifera seed, or seed and leaf, extract containing a combination of the flavonoids catechin and quercetin in a molar ratio in a range from 7:1 to 4:1, respectively, or a″) a mixture of Vitis vinifera extracts a) and a′), or a′″) a mixture of catechin and quercetin in a molar ratio in a range from 7:1 to 3:1, respectively, together with b) an olive, Olea europaea L, leaf extract having a hydroxytyrosol content in a range from 1% to 30% by weight of the extract, or b′) hydroxytyrosol in an amount equal to that contained in the b) extract.
Description
13 parts›This application is a national stage application under…
This application is a national stage application under 35 U.S.C. §371 of PCT Application No. PCT/EP2014/055162, filed Mar. 14, 2014, which claims the priority benefit of Italian Patent Application No. MI2013A000397, filed Mar. 15, 2013, which is hereby incorporated by reference in its entirety.
›FIELD OF THE INVENTION
The subject of the present invention is a flavonoid-based composition for pharmaceutical, nutritional or cosmetic use having potentiated antioxidant action against free radicals.
›PRIOR ART
Numerous studies demonstrate that the flavonoids, polyphenolic compounds present in nature as secondary metabolites in plants, possess an elevated antioxidant capacity against free radicals of oxygen (ROS), a well-known cause of degenerative diseases. Flavonoids are therefore indicated various applications in the medical field, for therapeutic as well as preventative purposes, for example in the treatment and prevention of cardiovascular disorders.
In the patent EP1328268 B1, the same Applicant, having summarised various of these studies as the prior art, describes a composition for pharmaceutical or dietetic use which has antioxidant activity, containing as the active principle a combination of the flavonoids catechin and quercetin, in a molar ratio in a range from 6:1 to 3:1, respectively. In particular, this combination of the two flavonoids obtained from an extract of a mixture of specific parts of Vitis vinifera , namely the seeds and the leaves, containing an average approximately 7.5 g of catechin and 1.5 g of quercetin per 100 g of extract. Among the indicated uses for this antioxidant composition, the patent proposes use as a platelet aggregation inhibitor in the treatment and prevention of cardiovascular disorders, the treatment and prevention of mental deterioration in old age, and the treatment and prevention of ageing of the skin.
French patent application 2947179 describes a composition having antioxidant properties comprising polyphenols obtained from a mixture of a grape extract rich in the flavonoid resveratrol and extract of the skin (epicarp or exocarp) of olives which is rich in maslinic acid, a triterpenoid C 30 H 48 O 4 , described therein as a protease inhibitor; selenium induced in proteins of the alga spirulina; vitamin E; the enzyme superoxide dismutase (SOD).
›DESCRIPTION OF THE INVENTION
This patent application compares the antioxidant capacity, or coefficient, of said polyphenols included in the composition, taken as such, i.e. substantially resveratrol and maslinic acid in admixture with each other, and of the composition itself, defined in this test (see the graph in FIG. 1 ) as a cocktail, that is, as a mixture of all the said ingredients, and it is found that this antioxidant capacity increases through the addition of the polyphenols of the other ingredients. According to the present invention, it is now being found that extracts of Vitis vinifera containing selected polyphenols, such as an extract of a mixture of seeds and leaves containing a combination of catechin and quercetin in a molar ratio within a defined interval as described in EP1328268, are capable of expressing a synergistically potentiated antioxidant action if an extract of leaves of the olive Olea europea L. having a content of hydroxytyrosol between 1% and 30% by weight of the extract is combined with these extracts.
As an alternative, the invention provides for use of analogous mixtures of the polyphenols catechin, quercetin and hydroxytyrosol as present in these extracts, in accordance with the same quantities.
The subject of the present invention is therefore a composition for pharmaceutical or nutritional or cosmetic use, possessing antioxidant activity against free radicals, comprising:
a) a Vitis vinifera seed, or seed and leaf, extract containing a combination of the flavonoids catechin and quercetin in a molar ratio in a range from 6:1 to 3:1, respectively, or
a′) a Vitis vinifera seed, or seed and leaf, extract containing a combination of the flavonoids catechin and quercetin in a molar ratio in a range from 7:1 to 4:1, respectively, or
a″) a mixture of Vitis vinifera extracts a) and a′), or
a′″) a mixture of catechin and quercetin in a molar ratio in a range from 7:1 to 3:1, respectively,
together with
b) an olive, Olea europaea L., leaf extract having a hydroxytyrosol content in a range from 1% to 30% by weight of the extract, or
b′) hydroxytyrosol in an amount equal to that contained in the b) extract.
Therefore the preferred embodiments of the invention are the following compositions, with reference to the said extracts a), a′) a)′″ of Vitis vinifera , and b) of olive, Olea europaea L.:
a)+b)
a′)+b)
a″)+b),
or the following compositions, with reference to the ingredients a′″) and b′):
a′″)+b)
a)+b′)
a′)+b′)
a″)+b′)
a′″)+b′)
In the embodiment providing for a″): a mixture of Vitis vinifera extracts a) and a′), catechin and quercetin are preferably present in the composition in a molar ratio generally within a range from 7:1 to 3:1, respectively.
According to a different embodiment of the invention, the composition also comprises: c) selenium, preferably in the form of selenium-enriched yeast.
Other embodiments of the invention may comprise other known compounds having antioxidant activity, for example zeaxanthin, rutin, ascorbic acid, vitamin E, zinc, copper.
Said olive, Olea europaea L., leaf extract b) has a content of hydroxytyrosol in a range from 1% to 30% by weight of the extract, preferably from 5% to 30%, yet more preferably at least 10%.
As a bibliographical reference to characterise the olive, Olea europaea L., leaf extract b) according to the composition of the invention, one may cite Benavente-Garcia et al., Antioxidant activity of phenolics extracted from Olea europaea L. leaves, Food Chemistry, vol. 68, no. 4, pp. 457-462, 2000, wherein is described a mixture of the following flavonoids with related absolute percentage content on dry basis (% d.s.):
The said Vitis vinifera seed, or seed and leaf, extract a) containing a combination of the flavonoids catechin and quercetin in a catechin/quercetin molar ratio in a range from 6:1 to 3:1 is preferably a dry extract having a total polyphenol content higher than 60%, and 15-20% oligomeric proanthocyanidins (OPC), obtained using ethanol/water as the extraction solvent.
The Vitis vinifera seed, or seed and leaf, extract a′) containing a combination of the flavonoids catechin and quercetin in a catechin/quercetin molar ratio in a range from 7:1 to 4:1 is preferably a dry extract having a total polyphenol content higher than 95%, and oligomeric proanthocyanidins (OPC) higher than 30%, extraction solvent ethanol/water.
A preferred extract according to a) and a′) is taken from seeds and leaves of Vitis vinifera containing a combination of the flavonoids catechin and quercetin in a molar ratio equal to approximately 5:1, respectively.
In what follows, a number of non-limiting examples of composition according to the invention, formulated for oral or topical use are described.
Topical use provides for an application of the composition on the skin or on the hair.
In the examples which follow, each active ingredient extract according to the invention is identified by the symbols a), a′), b) and c) as defined above more in general.
›Examples8
›Example 8
FACE CREAM - Composition a) + b) + c) Ingredient (INCI name) quantity p/p (%) Glycerin 2.00-5.00 Diglycerin 0.20-2.00 Cetearyl alcohol 0.20-2.50 Cetearyl glucoside 0.20-2.50 PEG-100 Stearate 0.20-1.00 Sorbityl furfural 0.5-1.00 Tetrasodium Glutamate Diacetate 0.10-0.50 Dry extract of Vitis vinifera L., a) 0.24-0.06 Olive Olea europea L. extract, b) 0.04-0.01 Selenium-enriched yeast, ingredient c) 0.06-0.015 Palm butter 0.50-3.00 Hydrogenated Evening Primrose Oil 0.50-3.00 Octyldodecanol 0.50-3.00 Hydrogenated castor oil 1.00-4.00 Ethylhexyl cocoate 1.00-4.00 Acrylates/C10-30 Alkyl acrylate crosspolymer 1.00-2.00 Butyrospermum parkii 1.00-5.00 Beta sitosterol 0.10-0.50 Tocopherol 0.05-0.20 Dimethicone 0.50-1.50 Dimethicone crosspolymer 0.10-1.50 Ethylhexylglycerin 0.25-0.50 Phenoxyethanol 0.50-0.99 Fragrance q.s. Aqua q.s. ad 100.00
Experimental Part—ORAC Test
Method
The antioxidant activity was measured as the ORAC (oxygen radical absorbance capacity) in accordance with the following test.
The ORAC test was performed according to the method described by Ou, Hampsch-Woodill and Prior, “Development and validation of an improved oxygen radical absorbance capacity assay using fluorescein as the fluorescent probe”, J Agric Food Chem 49 (10): 4619-26, (2001), with a number of modifications as described by Duais, Müller et al. (2009). The fluorescent probe used was fluorescein diluted in PBS (Phosphate buffered saline) (75 mmol/L, pH 7.4). A working solution equivalent to 1.2 μmol/L, fresh preparation from a 120 μmol/L stock solution stored in a refrigerator, was used for the analyses. The filters used in the microplate reader were a 485 nm filter (excitation) and a 520 nm filter (emission). The reaction was conducted in PBS 75 mmol/L (pH 7.4).
The following were pipetted into each well of the microplate: 10 μL of aqueous sample diluted as described below, 100 μL of PBS e 25 μL of the fluorescein solution (1.2 μmol/L) and preheated for 10 minutes at 37° C. Water was used as a blank and experimental control. However, for the calibration curve, Trolox (0.1-2.5 mmol/L) was used as a standard. The reaction starts with addition of a 129 mmol/L solution of AAPH (2,2′-azobis(2-amidino-propane) dihydrochloride) in PBS, freshly prepared and refrigerated on ice, and subsequent measurement of the fluoroscein for 2 h at 37° C. To check for the photostability of the fluoroscein, the same volume of PBS was added to a few of the wells.
To calculate the ORAC value, the relative fluorescence data at each minute were generated on the basis of the fluorescence intensity of the samples, the blank and the control. The area under the curve (AUC) was then calculated for each sample, equation (1):
AUC = 1 + ( f 1 + f 2 + f 3 + … f i f 0 ) ( 1 )
where f 0 represents the relative fluorescence at 0 minutes e f i the relative fluorescence at the time i. The AUC net was calculated by subtracting the AUC value of the blank from that of the sample or of the standard, equation (2):
AUC net =AUC sample/standard −AUC blank (2)
The final ORAC value, obtained from the AUC net value and the Trolox concentration with the use of a regression equation, is therefore expressed as Trolox® equivalents (TE) in mmol/100 g.
The value obtained is then subsequently converted into ORAC units (1 ORAC unit=1 μM of Trolox equivalents).
Samples
Using the test described here by way of example, the samples subjected to ORAC measurement were the extracts a) and b) as defined above, both individually as such for comparison purposes, and as compositions according to the present invention, as specified in what follows.
In particular, extract a) undergoing measurement herein is a dry extract of seeds and leaves of Vitis vinifera containing a combination of the flavonoids catechin and quercetin in a catechin/quercetin molar ratio equal to 5.2:1, respectively; total polyphenols>60% (UV), catechin 3.0% (HPLC), quercetin 0.6% (HPLC); extraction solvent ethanol/water.
The selected reference for comparison purposes was a dry extract of skin of the Vitis vinifera grape titrated into resveratrol, having a content of total polyphenols higher than 70%, of oligomeric proanthocyanidins higher than 15%, of resveratrol higher than 100 ppm, extraction solvent ethanol/water. This comparison extract is here defined by the symbol Ref.).
The following extracts were tested individually:
Extract of the seeds and leaves of Vitis vinifera a), 60 mg in quantity Grape skin extract Ref.), 60 mg in quantity Olive leaf extract b), 30 mg in quantity, symbol b) 30 Olive leaf extract b), 10 mg in quantity, symbol b) 10
The following compositions were tested: a)+b) according to the invention and Ref.)+b) as the reference for comparison purposes:
a)+b), where a): b) are in a ratio by weight equal to 6:3, respectively. a)+b), where a): b)=6:1. Ref.)+b), where Ref.): b)=6:3 Ref.)+b), where Ref.): b)=6:1
Results
The data obtained are presented in the table below, wherein ORAC is measured in micromoles of Trolox equivalent (TE) for weight of the sample, expressed in mg.
›DESCRIPTION OF THE DRAWINGS
The data shown in table form are also presented graphically in FIGS. 1 and 2 of the attached drawings, which show on the ordinate the ORAC values measured in micromoles of trolox equivalent (TE) for the individual ingredients and for the respective compositions as here defined.
FIG. 1 relates to the comparison between the individual extracts a) of Vitis vinifera seeds and leaves, b) 30 and b) 10 of olive leaves as mentioned above, versus the respective compositions a)+b) 30 and a)+b) 10 , in order.
FIG. 2 relates to the comparison between individual Ref. extracts) of Vitis vinifera grape skin, b) 30 and b) 10 of olive leaves as mentioned above, versus the respective compositions Ref.)+b) 30 e Ref.)+b) 10 , in order.
For the compositions of the invention a)+b) 30 and a)+b) 10 , FIG. 1 shows an increase in ORAC of 72% and 63% respectively, with respect to the ORAC algebraic sum of the individual ingredients, extracts a) and b), therefore an increase of synergistic type.
By contrast, for both the comparison compositions Ref.)+b) 30 and Ref.)+b) 10 we actually find a reduction (approximately −10% and −30%, respectively) in respect of the ORAC algebraic sum of the individual ingredients, extracts Ref. and b).
These experimental results demonstrate on the one hand the importance of selecting extracts of Vitis vinifera such as a), and similarly a′) or a″), or of their synthetic analogue a′″) according to the present invention, i.e. containing the polyphenols catechin and quercetin in a molar ratio within a specific range, as compared with other Vitis vinifera extracts such as Ref., which is an extract of skin of the Vitis vinifera grape titrated in resveratrol, a different polyphenol.
On the other hand, according to the present invention it must be considered totally surprising that the known antioxidant activity of the Vitis vinifera extracts in question can be synergistically potentiated by addition of an olive extract b), or of a synthetic analogue thereof b′), which as such has an inferior antioxidant activity as compared with each of the Vitis vinifera extracts discussed here, whether they are of the type a), or similar according to the invention, or Ref.), not part of the invention.
›Tables in the description — 9
| Hydroxytyrosol | 1.46 |
| Tyrosol | 0.71 |
| Catechin | 0.04 |
| Caffeic acid | 0.34 |
| Vanillic acid | 0.63 |
| Vanillin | 0.05 |
| Rutin | 0.05 |
| Luteolin-7-glucoside | 1.38 |
| Verbascoside | 1.11 |
| Apigenin-7-glucoside | 1.37 |
| Diosmetin-7-glucoside | 0.54 |
| Oleuropein | 24.54 |
| Luteolin | 0.21 |
| Diosmetin | 0.05 |
| Ingredient | quantity u.m. | |
|---|---|---|
| Granular L-methionine | 300 | mg |
| Spermidine trihydrochloride | 0.50 | mg |
| Zeaxanthin | 2.00 | mg |
| Rutin | 2.50 | mg |
| Calcium d-pantothenate | 9.0 | mg |
| d-Biotin | 0.050 | mg |
| Ascorbic acid | 90.0 | mg |
| Vitamin E acetate | 15.0 | mg |
| Pyridoxine hydrochloride | 2.43 | mg |
| Zinc bisglycinate | 26.6 | mg |
| Copper bisglycinate | 4.0 | mg |
| Folic acid | 0.30 | mg |
| Dry extract of Vitis vinifera L . . . ingredient a′) | 60.0 | mg |
| Extract of olive Olea europea L . . . ingredient b) | 10.0 | mg |
| Selenium-enriched yeast ingredient c) | 15.0 | mg |
| Croscarmellose sodium | 25.0 | mg |
| Dicalcium phosphate | 25.0 | mg |
| Microcrystalline cellulose | 65.0 | mg |
| Magnesium stearate | 8.0 | mg |
| Silicon dioxide | 5.0 | mg |
| Ingredient | quantity u.m. | |
|---|---|---|
| Dry extract of Vitis vinifera , a) | 30.0 | mg |
| Olive Olea europea L. extract), b) | 10.0 | mg |
| Dicalcium phosphate | 300.0 | mg |
| Microcrystalline cellulose | 300.0 | mg |
| Mixture of behenic acid mono-, di-and triglycerides | 8.0 | mg |
| Silicon dioxide | 5.0 | mg |
| Each hard gelatin capsule contains: | quantity u.m. |
| Dry extract of Vitis vinifera L., a′) | 30.0 mg |
| Olive Olea europea L. extract, b) | 5.0 mg |
| Maltodextrin | 50.0 mg |
| Magnesium stearate | 2.0 mg |
| Silicon dioxide | 3.0 mg |
| Natural gelatin | Outer shell |
| Each sachet contains: | quantity u.m. | |
|---|---|---|
| Dry extract of Vitis vinifera L., a′) | 40.0 | mg |
| Olive Olea europea L. extract, b) | 10.0 | mg |
| Fructose | 0.445 | g |
| Maltodextrin | 1.50 | g |
| Flavouring | 10.0 | mg |
| Sucralose | 0.005 | mg |
| Ingredient (INCI name) | quantity p/p (%) |
|---|---|
| Disodium Laureth Sulfosuccinate | 1.00-5.00 |
| Magnesium Laureth Sulfate | 5.00-9.00 |
| PEG-7 Glyceryl Cocoate | 0.50-1.00 |
| Cocamide MIPA | 0.50-2.00 |
| Peg-200 Hydrogenated Glyceryl Palmate | 0.50-2.00 |
| Polyquaternium-10 | 0.10-0.50 |
| Tetrasodium EDTA | 0.05-0.20 |
| Sodium Lauroyl Sarcosinate | 1.00-4.00 |
| Tetrasodium EDTA | 0.05-0.20 |
| Dry extract of Vitis vinifera L., a′) | 0.12-0.03 |
| Olive Olea europea L. extract, b) | 0.04-0.005 |
| BHA | 0.005-0.015 |
| Potassium Undecilenoyl Wheat Protein | 0.50-1.00 |
| Phenyl Trimethicone | 0.5-1.50 |
| Silicone Quaternium-15 | 0.01-0.07 |
| Laureth-4 | 0.01-0.80 |
| Fragrance | 0.10-0.80 |
| Glycol Distearate | 0.50-1.00 |
| Laureth-7 | 0.50-0.80 |
| Sodium Cocoamphoacetate | 0.05-3.00 |
| Cocamidopropyl Betaine | 0.01-2.00 |
| Sodium Laureth Sulfate | 0.01-3.00 |
| Sodium Hydroxymethylglycinate | 0.20-0.45 |
| Benzoic acid | 0.005-0.10 |
| Sodium hydroxyde | q.s. |
| Citric acid | q.s. |
| Aqua | q.s. ad 100.00 |
| Ingredient (INCI name) | quantity p/p (%) |
|---|---|
| Propylene glycol | 1.00-5.00 |
| C12-15 alkyl benzoate | 5.00-7.00 |
| Ethylexyl methoxycinnamate | 3.00-7.00 |
| Dry extract of Vitis vinifera L., a′) | 0.12-0.03 |
| Olive Olea europea L. extract, b) | 0.04-0.005 |
| Isostearyl isostearate | 2.00-8.00 |
| Styrene/Acrylates Copolymer | 1.00-5.00 |
| Acrylates/C10-30 Alkyl Acrylate Crosspolymer | 0.05-0.70 |
| Butylene glycol cocoate | 1.00-5.00 |
| Butyl methoxydibenzoylmethane | 1.00-5.00 |
| Hydroxybenzoyl Hexyl Benzoate diethylamine | 1.00-5.00 |
| Ethylhexyl Triazone | 1.00-5.00 |
| Octocrylene | 1.00-5.00 |
| PPG-15 stearyl ether | 1.00-5.00 |
| Diethylhexyl syringylidene malonate | 0.10-1.00 |
| Sorbityl furfural | 0.05-0.10 |
| Ethylhexylglycerin | 0.15-0.60 |
| Polyperfluoroethoxymethoxy Difluoroethyl PEG | 0.2-1.50 |
| Phosphate | |
| Fragrance | 0.1-0.5 |
| Phenoxyethanol | 0.80-1.00 |
| Sodium Hydroxide | q.s |
| Aqua | q.s. ad 100.00 |
| Componente (INCI name) | quantity p/p (%) |
|---|---|
| Denat. alcohol | 10.00-30.00 |
| Disodium EDTA | 0.025-0.20 |
| Dry extract of Vitis vinifera L., a′) | 0.12-0.03 |
| Olive Olea europea L. extract., b) | 0.04-0.005 |
| Biotin | 0.001-0.005 |
| Fragrance | 0.30 |
| Ajuga reptans leaf extract | 0.01-0.05 |
| Calcium pantothenate | 0.05-0.40 |
| PEG-40 Hydrogenated Castor Oil | 0.20-1.00 |
| Aqua | q.s. ad 100.00 |
| Sum of | Variation | |||
|---|---|---|---|---|
| ORAC | ORAC | in | ||
| (TE | individual | ORAC in | ||
| Ingredients and | micromoles | ingre- | composi- | |
| compositions | over × mg) | dients | tions | |
| a) | Vitis vinifera seeds and | 212.4 | — | — |
| leaves extract, 60 mg | ||||
| Ref.) | Vitis vinifera grape skin | 388.2 | — | — |
| extract, 60 mg | ||||
| b) 30 | Olive leaf extract 30 mg | 66.9 | — | — |
| b) 10 | Olive leaf extract 10 mg | 22.3 | — | — |
| a) + | Vitis vinifera seeds and | 481.5 | 279.3 | +72% |
| b) 30 | leaves + Olive leaf | |||
| extract 30 mg 6:3 | ||||
| a) + | Vitis vinifera seeds and | 382.2 | 234.7 | +63% |
| b) 10 | leaves + Olive leaf | |||
| extract 10 mg 6:1 | ||||
| Ref.) + | Vitis vinifera grape | 411.3 | 455.1 | −10% |
| b) 30 | skin + Olive leaf | |||
| extract 30 mg 6:3 | ||||
| Ref.) + | Vitis vinifera grape | 288.4 | 410.5 | −30% |
| b) 10 | skin + Olive leaf | |||
| extract 10 mg 6:1 |
Claims as granted
17 claimsLog in to read the claims of this application.
Log in to unlockClassifications
27 codes- A61K8/23
- A61K8/49
- A61K31/05
- A61K45/06
- A61K8/97
- A61K9/00
- A61K8/27
- A61K36/06
- A61K36/87
- A61K31/353
- A61K36/63
- A61K33/04
- A23L33/105
- A61K33/34
- A61Q19/08
- A61K31/047
- A61Q19/00
- A61Q7/00
- A61K31/375
- A61K8/60
- A61K31/7048
- A61K8/34
- A61Q5/02
- A61Q5/00
- A61K33/30
- A61K31/355
- A61K8/19
Claim changes
SoonSee which claims were amended, added or cancelled during examination, with every added and removed word marked.
The published claims of this application are not paired with the granted ones in what we hold.
File wrapper
See the full prosecution history — every USPTO and applicant action on this file, in order.
Log in to unlockDocuments
Log in to open the documents of this file: the application as filed, every office action and response, the notice of allowance.
Log in to unlockChain of title
See the full assignment history — every owner this patent has passed through, with recordation dates and reel/frame numbers.
Log in to unlock